On axial CT images of the neck, the structure immediately posterior to the trachea is the ...

Author Question: On axial CT images of the neck, the structure immediately posterior to the trachea is the ... (Read 90 times)

armygirl

Hero Member
Posts: 556

on: Jul 17, 2018

On axial CT images of the neck, the structure immediately posterior to the trachea is the ___________________ _.
Fill in the blank(s) with correct word

Question 2

The muscle seen most anteriorly on axial CT images of the neck is the ___________________ _.
Fill in the blank(s) with correct word

ultraflyy23

Sr. Member
Posts: 312

Reply #1 on: Jul 17, 2018

Answer to Question 1

esophagus

Answer to Question 2

platysma

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.